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We have previously examined the mechanism of antimicrobial peptides on the outer membrane of vaccinia virus. We show here
that the formulation of peptides LL37 andmagainin-2B amide in polysorbate 20 (Tween 20) results in greater reductions in virus
titer than formulation without detergent, and the effect is replicated by substitution of polysorbate 20 with high-ionic-strength
buffer. In contrast, formulation with polysorbate 20 or high-ionic-strength buffer has the opposite effect on bactericidal activity
of both peptides, resulting in lesser reductions in titer for both Gram-positive and Gram-negative bacteria. Circular dichroism
spectroscopy shows that the differential action of polysorbate 20 and salt on the virucidal and bactericidal activities correlates
with the-helical content of peptide secondary structure in solution, suggesting that the virucidal and bactericidal activities are
mediated through distinct mechanisms. The correlation of a defined structural feature with differential activity against a host-
derived viral membrane and the membranes of both Gram-positive and Gram-negative bacteria suggests that the overall helical
content in solution under physiological conditions is an important feature for consideration in the design and development of
candidate peptide-based antimicrobial compounds.
Antimicrobial peptides (AMPs) exhibit potent, broad-spec-trum bactericidal activity and have been shown to be active
against a limited number of viruses (1). They are typically 15 to 40
amino acids in length and variously display the structural charac-
teristics of -helices, -sheets, or disordered chains. Some AMPs
combine multiple structural elements, and many are stabilized or
constrained by intramolecular disulfide bonds or cyclized into
circular or loop structures (reviewed in reference 1).
Helical content is an important factor in the microbicidal ac-
tivity of AMPs, with increased helical content in hydrophobic en-
vironments or lipid or detergent micelles seen as a marker for
potent microbicidal activity (2–5). For many linear peptides,
physiological salt concentrations inhibit microbicidal activity (6,
7). However, -helical structure of cathelicidin peptides is pro-
moted by elevating the ionic strength of buffers, which correlates
with inhibition of antimicrobial activity (8, 9), and there is con-
tinuing debate on themechanistic function of secondary structure
for antimicrobial activity. The profound microbicidal activity of
AMPs warrants a fuller understanding of their mechanisms of
action in order to realize their potential as treatments that avoid
resistance mechanisms that apply to conventional antibiotics.
LL37 is a 37-mer -helical AMP derived posttranslationally
from human cathelicidin. It has microbicidal activity against both
Gram-positive and Gram-negative bacteria and viruses (10).
Studieswithmultiple primate cathelicidins show that LL37homo-
logues with lower propensity to adopt -helical conformation in
solution have more potent bactericidal activity, which is less sus-
ceptible to inhibition by physiological concentrations of salt (8, 9).
LL37 itself will readily adopt -helical conformation in solution;
this is enhanced at physiological salt concentrations, while its bac-
tericidal activity is inhibited.
Salt-dependent conformation change is also a feature of the
Xenopus laevis AMP magainin, which adopts a greater degree of
-helicity in solutions containing increased salt, while its bacteri-
cidal activity is reduced (3, 11–14). Althoughmagainin hasmainly
a disordered conformation at physiological salt concentrations, it
has been shown to adopt an-helical conformation in lipidmem-
branes (2, 3, 15). Enhanced -helical folding in lipid membranes
is also observed for LL37 (5), and it is thus possible that whereas
adoption of -helical structure is important for antimicrobial ac-
tivity of this class of AMP, the point at which the AMP adopts the
-helical structure is equally important, and that preformed heli-
ces are less able to disrupt the target membranes.
We have previously shown that LL37 and alanine substituted
(S8A, G13A, and G18A) magainin-2 amide (magainin-2B) could
inactivate vaccinia virus (VACV) but were unable to inactivate all
the virus in a preparation, generally leaving a viable rump of ca.
10% of the starting preparation (16). In this study, we sought to
improve the activity of AMPs against VACV by formulation with
the nonionic detergent, polysorbate 20 (Tween 20). Experiments
were also undertaken with Gram-positive Staphylococcus aureus
and Gram-negative Escherichia coli bacteria to determine whether
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modulation of microbicidal activity applied equally to different
types of microbial membranes. We analyzed the effect of the de-
tergent on the secondary structure of LL37 and magainin-2B by
circular dichroism (CD) spectroscopy and correlated this with the
effect of ionic strength on secondary structure and with the effect
of both detergent and ionic strength on activity against S. aureus,
E. coli, and VACV.
MATERIALS AND METHODS
Reagents. Unless otherwise stated, all reagents were purchased from
Sigma-Aldrich Chemical Company.
Cell lines and viruses. Enveloped virions of the IHD-J strain of vac-
cinia virus were harvested at 18 to 20 h postinfection from the culture
supernatant of RK13 rabbit epithelial cells synchronously infected at a
multiplicity of infection of10 to provide virions with undamaged enve-
lopes. All cell and virus cultures were maintained in DMEM with 10%
fetal bovine serum, 2 mM L-glutamine, and 100 U of penicillin and strep-
tomycin ml1 (tissue culture medium) at 37°C in a 5% CO2, humidified
atmosphere. Virus was used fresh on the day of preparation and was
quantitated by limiting dilution titration on RK13 cells, and the 50%
tissue culture infectious dose was calculated by Reed-Muench analysis of
virus-positive wells (17, 18). The entire volume of the sample was used in
titrations. The requirement for virus to be used as a fresh preparation
meant that starting virus titer could not be determined in advance of the
experiments and was always determined from control samples as part of
the experiment.
Bacterial strains. E. coli strain XL1-Blue was obtained from Strat-
agene, and S. aureus strain ATCC-29213 was obtained from the American
Type Culture Collection. For bacterial cultures, a single colony grown on
L agar plates (S. aureus) or a loop from a frozen ampoule obtained direct
from the supplier (E. coli) was inoculated directly into 5ml of L broth in a
vented T25 tissue culture flask. Two serial dilutions were taken using fresh
loops into further T25 flasks containing 5ml of L broth, and all three flasks
were cultured overnight, upright in a shaking incubator at 37°C, after
which the most dilute flask with visual turbidity was selected. A sample of
the culture was diluted in H2O to give an absorbance reading of between
0.01 and 0.02 at 600 nm, and this was used for incubation with AMPs.
After incubationwithAMPs for 10min, bacterial cultures were serially
diluted in steps of 1:3, applied in spots to L agar plates (8 spots per dilu-
tion, in 10-l volumes), and cultured overnight at 37°C. After this, each
spot was evaluated for bacterial growth, and the data were used to calcu-
late a 50% colony-forming dose by the method of Reed and Muench (17,
18). The entire volume of the sample was used in titrations.
Peptides.Peptides were synthesized byAlta Biosciences, Birmingham,
United Kingdom. The LL37 sequence used was LLGDFFRKSKEKIGKEF
KRIVQRIKDFLRNLVPRTES (19). The magainin-2B sequence used was
GIGKFLHAAKKFAKAFVAEIMNS, with the C terminus amidated (11).
Unless otherwise stated, peptide stocks were made at 1 mg/ml in phos-
phate-buffered saline (PBS).
Peptide treatments. Peptides were dispensed into tubes at a 10 con-
centration. Negative controls received an equivalent volume of PBS with
no peptide. For treatment in the presence of polysorbate 20 (Tween 20),
an appropriate volume of 10 concentration (vol/vol in H2O) polysor-
bate 20 or H2O was added to the peptide and control samples and then
mixed by vortexing. Finally, the virus or bacteria were added, and the
samples were vortexed and incubated at 37°C. Sample volumes were al-
ways 50 l. At the end of the incubation, samples were diluted by the
addition of 130 l of tissue culture medium for virus or 130 l of L broth
for bacteria and then quantitated as described above. In eachmicrobicidal
activity experiment, all samples were prepared in triplicate, and all data
are presented as means and standard deviations of triplicates.
CD spectroscopy. CD spectra were recorded on an Aviv model 215
spectropolarimeter (Aviv Biomedical, Inc., Lakewood, NJ) equipped with
a thermostated cell holder. Far-UV spectra (260 to 190 nm) were col-
lected in a 0.1-cm quartz cuvette at peptide concentrations of 0.1 to 0.2
mg/ml determined spectroscopically (20). Buffer baselines (with or with-
out polysorbate 20) recorded in the same cell were subtracted, and data
were smoothed and normalized to mean residue ellipticities ([]MRW).
The instrument was calibrated with camphorsulfonic acid (21). Lyophi-
lized peptides were dissolved in 150mMNaF and 20mMKH2PO4/NaOH
(pH 7.4). NaF was used instead of NaCl due to the strong absorbance of
chloride ions below   195 nm. Polysorbate 20 in the same buffer was
added to peptide samples at least 1 h prior to measurements.
The fraction of -helical peptide conformation was calculated as de-
scribed previously (22). Detergent-induced -helix formation was mon-
itored at 222 nm, and data were fitted assuming a one-site binding mech-
anism, fH	 fh
max c/(Kd
 c), where f
H is the fraction of helix, fh
max is
the maximum helix fraction achievable, and Kd is the apparent dissocia-
tion constant.
Statistical analysis. For statistical analysis, the raw data were trans-
formed by taking the log10 of each data-point prior to analysis of variance
(ANOVA). The experimental design facilitates the combination of repeat
experiments into a single analysis using a two-way ANOVA where one of
the parameters is variation between experiments. It is to be expected that
in some cases there will be significant variation between repeat experi-
ments because the starting titer of virus and bacterial preparations is not
known in advance. However, in all cases where there was a significant
variation between experiments, the analysis showed that there was no
interaction between the interexperiment variation and the effects, if any,
of AMP treatment.
RESULTS
Virucidal activity of AMPs is enhanced synergistically by poly-
sorbate 20.We have previously shown that LL37 has greater viru-
cidal activity against VACV than magainin-2B but that both re-
move the outer membrane of the virus (16). The efficacy of LL37
in inactivating VACV led us to examine methods by which the
activity of magainin-2B might be improved. Thus, we took prep-
arations of VACV and treated them with LL37 or magainin-2B in
the presence or absence of the nonionic detergent, polysorbate 20,
at a concentration above the critical micellar concentration, on
the assumption that the detergentwould alter the secondary struc-
ture of the AMPs. LL37 treatment significantly reduced the quan-
tity of virus recovered (P	 0.004) while magainin-2B had a lesser
and insignificant effect (P	 0.1) in the absence of polysorbate 20
(Fig. 1A). When incubated with virus in the presence of polysor-
bate 20 for 1 h,magainin-2B acquired significant virucidal activity
(0.001) and a significant enhancement of the activity of LL37
(P	 0.004) was also observed (Fig. 1B). Treatment with polysor-
bate 20 alone for 60 min produced a slight increase in titer, pre-
sumably as a result of disaggregation of virus particles (data not
shown).
The improved activity of both LL37 and magainin-2B against
VACV in the presence of polysorbate 20 led us to determine
whether the AMP and the detergent were acting independently or
cooperatively. Virus was treated with magainin-2B and subse-
quently with polysorbate 20 after first washing away the AMP or
vice versa. To control for the necessity of incubating treated con-
trols for a further 90 min after the first treatment, replicate sam-
ples were treated with polysorbate 20 for 90 min, followed by PBS
for 90 min, with a parallel group treated with PBS for 90 min,
followed by polysorbate 20 for 90 min. A similar approach was
takenwith themagainin-2B controls. As expected, both treatment
with PBS followed by magainin-2B (P	 0.123) and magainin-2B
followed by PBS (P 	 0.009) produced a slight effect, although
only in the latter case was this significant. Polysorbate 20 alone
produced an unexpected significant reduction in virus titer when
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the first incubation was in PBS (P 	 4.61  105), possibly as a
result of increasing the incubation time to 90 min and a nonspe-
cific detergent-like effect on the viral membrane. This was even
more apparent when the polysorbate 20 treatment preceded the
PBS treatment (P 	 5.64  108), and the difference between
polysorbate 20 as the first treatment and polysorbate 20 as the
second treatment in these control samples was significant (P 	
2.17  105) (Fig. 2). This is likely to reflect a time-dependent
degradation of virus membranes by the detergent and fits with
previous observations demonstrating the time-dependent effect
of polysorbate 20 on the density of VACV virions (16).
Where samples were sequentially treated with magainin-2B
and polysorbate 20, or vice versa, treatment with detergent first
gave a level of virus inactivation that was similar to treatment with
detergent first and then subsequently with PBS. Treatment with
magainin-2B first yielded a level of inactivation that was similar to
that seen when treating with PBS first and then subsequently with
detergent. This indicates that treatment with AMP and detergent
sequentially is equivalent to omitting the AMP. Importantly,
treatment with magainin-2B and polysorbate 20 in combination,
followed by a subsequent treatment with PBS, yielded a level of
inactivation that was significantly greater than all other combina-
tions (P values ranged from 4.32 104 to 8.67 108) (Fig. 2).
This suggests that magainin-2B and polysorbate 20 may act syn-
ergistically to inactivate VACV and that the effect on VACV of
either in isolation does not render the virus particlesmore suscep-
tible to the other in isolation.
The observation of virucidal activity for polysorbate 20 after a
90-min incubation, while a 60-min incubation did not reduce
virus titers in previous experiments (data not shown), suggested
that the effects of both detergent and AMP might be time depen-
dent. Accordingly, we examined the effects of polysorbate 20 and
magainin-2B or LL37 separately and in combination over a range
of incubation times.Magainin-2Bwas timedependent in its effect,
taking more than 60 min to inactivate a significant proportion of
the virus in the sample relative to the PBS controls (P 	 0.003)
(Fig. 3A). The effect on LL37 was not time dependent in these
experiments, which may reflect the greater virucidal efficacy of
this AMP for VACV (Fig. 3B). The time dependency of polysor-
bate 20 virucidal activity varied considerably between experi-
ments. However, in all experiments when detergent and either
AMP were combined, an enhanced effect was seen after a 30- or
60-min incubation, relative to PBS, polysorbate 20 alone, or AMP
FIG 1 Treatment of VACV preparations with LL37 or magainin-2B. In sepa-
rate experiments virus preparations in equal volumes were adjusted, to 0 ()
or 100 (o)gml1 LL37 ormagainin-2B in the absence (A) or presence (B) of
0.5% (vol/vol) polysorbate 20 for 60 min. Virus was quantitated by Reed-
Muench limiting dilution. Data are presented as means and standard devia-
tions of triplicate samples. Each panel is one representative of2 experiments.
FIG 2 Treatment of VACVpreparations withmagainin-2B in the presence and absence of polysorbate 20. Virus preparations were divided into 24 equal aliquots
and treated sequentially with PBS, followed by PBS; PBS, followed bymagainin-2B;magainin-2B, followed by PBS; PBS, followed by polysorbate 20; polysorbate
20, followed by PBS; magainin-2B, followed by polysorbate 20; polysorbate 20, followed bymagainin-2B; or magainin-2B and polysorbate 20 together, followed
by PBS (groups 1 to 8, respectively, in the figure). Magainin-2B was used at 100 g ml1, and polysorbate 20 was used at 0.5% (vol/vol). Sequential incubations
were for 90 min each, with the virus being washed twice in between the two treatments. After the second wash, the virus was resuspended directly in the second
treatment in 50-l volumes. After the second treatment, the samples were adjusted to 200 l with tissue culture medium and subjected to manual Potter-
Elvejhem homogenization and titration without additional washes. Data are presented as means the standard deviations of triplicate samples. The results of
one representative experiment of two experiments are shown.
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alone (P values ranged from1.1 105 to 2.4 1012), providing
further evidence of a synergistic interaction between the two.
Synergism between AMP and polysorbate 20 suggests that the
effect is mediated by alteration of the AMP secondary structure in
solution, prior to AMP interaction with the target membrane.
This has implications for the future development of AMPs as po-
tential anti-infective agents, since it demonstrates that formula-
tion in aqueous solution can significantly affect their activity.
Polysorbate 20 increases the -helical content of AMPs in
aqueous solution.The apparent synergy betweenAMPs andpoly-
sorbate 20 for inactivation of VACV led us to examine the second-
ary structure of the AMPs in the presence or absence of polysor-
bate 20 by CD spectroscopy. In salt-containing buffer, the
magainin-2B CD spectrum shows the characteristics of an unor-
dered structure with a pronounced minimum at200 nm and a
shoulder of negative ellipticity at227 nm (Fig. 4A). These char-
acteristics are also observed at 2°C, at which the magnitude of the
FIG 3 Time course of AMP and polysorbate 20 activity against VACV. Virus
preparationswere divided into equal aliquots and adjusted to 0 or 100gml1
magainin-2B (A) or LL37 (B) and/or 0 or 0.5% (vol/vol) polysorbate 20 and
incubated at 37°C for 30 (), 60 (o), 90 ( ), or 120 (p) min. Virus was
quantitated byReed-Muench limiting dilution.Data are presented asmeans
the standard deviations of triplicate samples. The results of one representative
experiment of two experiments are shown.
FIG 4 CD spectroscopy. Far-UV CD spectra were recorded for magainin-2B
(A) and LL37 (B) in the absence or presence of 0.40% polysorbate 20 (solid
lines) at 37°C. Dashed lines represent spectra recorded at detergent concentra-
tions (from the top to the bottom at 220 nm) of 0.01, 0.02, 0.05, 0.10, and
0.20% (vol/vol). Insets show the degree of -helicity derived from the []222
plotted as a function of the molar detergent/peptide ratios.
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signal is about 1.5 times greater (data not shown). In the presence
of 0.4% (vol/vol) polysorbate 20, the spectrum shows minima at
208 and 222 nm and a positivemaximumat 192 nm,which are the
characteristic CD bands for an -helical conformation. Spectra
recorded upon titration of polysorbate 20 (from 0.01 to 0.40%)
exhibit a single isodichroic point at 203 nm, which is compatible
with the assumption that the coil-to-helix conversion occurs as a
two-state process. Data fitting results in an apparent Kd	 0.48
0.09 mM with a maximum -helix content of 16.9 0.7%. Half-
maximal change in helicity is found at a 4.1:1 detergent/peptide
ratio corresponding to0.05% polysorbate 20 (Fig. 4A, inset).
The CD spectrum of LL-37 in salt-containing buffer is indica-
tive for a pronounced -helical conformation (Fig. 4B), whereas
in the absence of salt it shows the characteristics of an unordered
structure (23). The calculated -helix content of 35% at 37°C is
only slightly lower than the 38% observed at 2°C. The spectra are
in quantitative agreement with those reported earlier (23). Upon
addition of polysorbate 20, the CD intensities increase, reaching
half-saturation at a detergent/LL37 ratio of 4.1  0.5 corre-
sponding to a Kd	 0.23 0.03 mM and a maximal -helix con-
tent of 45.5%  0.3% (Fig. 4B, inset). Also in this case, spectra
recorded at increasing polysorbate 20 concentrations show a sin-
gle isodichroic point at 203 nm.
It is already known that AMPs adopt-helical conformation in
target membranes. Our findings suggest that, at least for VACV, it
is important that -helical conformation is achieved before the
AMP comes into contact with the membrane. It is interesting that
the effect of polysorbate 20 on -helical content of the AMP par-
allels that of elevated ionic strength buffer, which is known to
inhibit bactericidal activity of AMPs. This suggests that the en-
hanced activity observed against VACVmight not apply to bacte-
rial targets.
The bactericidal activity of AMPs is attenuated by polysor-
bate 20 or elevated ionic strength. The parallel effects of increas-
ing ionic strength and increasing detergent concentration on
AMP-helix content led us to examine the effect of polysorbate 20
on bactericidal activity of the AMPs. The salt-dependent inhibi-
tion of AMP bactericidal activity shown by others was confirmed
with E. coli bacteria treated in the presence of increasing concen-
trations of NaF (to mirror conditions used in CD spectroscopy)
andNaCl, with amarked inhibition of bactericidal activity at high
ionic strength (P values ranged from 5.7  109 to 3.7  1011,
except for magainin-2B in the presence of NaCl, where salt con-
centration did not affect AMP activity, and P	 0.56) (Fig. 5A and
B). The effect of NaF was also examined for S. aureus, with a
similar result (P values of 7.6 109 and 2.1 1012) (Fig. 5C).
When E. coli experiments were repeated with polysorbate 20 in-
stead of salt, an effect opposite that seenwith VACV and similar to
that seen against bacteria in the presence of salt was observed (Fig.
6). The bactericidal activity of the AMPs was reduced by formu-
lation with polysorbate 20 (P	 0.03 for LL37 and P	 9.8 109
for magainin-2B).
These data show correlation of the effects of polysorbate 20 and
salt on the bactericidal activity of AMPs just as the effects of poly-
sorbate 20 and salt on AMP secondary structure in aqueous solu-
tion are correlated. The correlations suggest a mechanistic rela-
tionship between the observed secondary structure and the levels
of bactericidal activity.
The virucidal activity of AMPs is enhanced by elevated ionic
strength.When virucidal activity of the AMPs was assessed in the
presence of NaF, an enhancement of activity was observed analo-
gous to the situation with virucidal activity in the presence of
polysorbate 20 and opposite the effect observed in the treatment
of bacteria (P 	 0.03 for LL37 and P 	 0.003 for magainin-2B)
FIG 5 Attenuation of AMP antibacterial activity by NaF and NaCl. E. coli (A
and B) or S. aureus (C) bacteria were incubated with either LL37 or
magainin-2B amide at a concentration of 100 g ml1 for 10 min in H2O.
Peptides and vehicle (1/10 dilution of PBS in H2O) controls were adjusted to
either 500 (), 250 (p), or 0 (o) mM NaF (B and C) or 500 (), 250 (p), or
11 (o) mM NaCl (A) before the addition of bacteria. After incubation with
AMP for 10min at room temperature, samples were serially diluted in L broth
and plated on L agar plates, followed by incubation overnight at 37°C. After
this, the colonies were enumerated for 50% CFU using the Reed-Muench
method. †, No colonies were recovered (100% kill).
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(Fig. 7). This further correlates the effects of polysorbate 20 and
salt on virucidal activity; the differential direction of potentiation
against bacteria and VACV is also correlated, strengthening the
interpretation that the AMP secondary structure in aqueous solu-
tion is important for membrane attack.
Potentiation of virucidal activity by elevated ionic strength was
also examined for a second virus, Semliki Forest virus (SFV), of
the alphavirus genus of the family Togaviridae. However, neither
LL37 normagainin-2B had any activity against SFV either in high-
or low-ionic-strength buffer (see Fig. S1 in the supplemental ma-
terial). Polysorbate 20 was not included in the SFV experiments
since neither AMPhad baseline activity against the virus and poly-
sorbate 20 inactivates the related Venezuelan equine encephalitis
virus by itself (D. Ulaeto, unpublished data). There is much less
data in the literature on the effect of AMPs on viruses, suggesting
a general lower susceptibility of enveloped viruses to inactivation
by AMPs. Interestingly, unlike SFV, which obtains its envelope
from the plasma membrane, VACV obtains its outer envelope
from the Golgi apparatus. The failure of the AMPs to degrade SFV
does not alter our interpretation of the data with bacteria and
VACV, demonstrating opposite effects of altered secondary struc-
ture on microbicidal activity of the AMPs on the two types of
membrane. This is highly suggestive ofmultiple, distinctmodes of
attack residing in the same peptide.
DISCUSSION
Elevated-ionic-strength buffer is known to attenuate the bacteri-
cidal activity of AMPs (6, 7). We have confirmed this and demon-
strated in the same system that polysorbate 20 has the same effect
of attenuating activity. Our interpretation is that the modulation
mediated by polysorbate 20 and salt is likely to be due to their
stabilization of -helical content in solution.
The VACV envelope is derived from the host trans-Golgi net-
work and is thus zwitterionic, unlike the bacterial membranes of
E. coli and S. aureus, which are anionic. This would be expected to
influence the interaction with AMPs, which generally carry a net
positive charge (LL37, 
6; magainin-2B, 
4) (4). Small linear
AMPs are often largely unstructured in water, althoughmany will
adopt some -helical structure in ionic buffer solutions and, in
some cases, those with a greater propensity to form an -helix in
solution are able to more aggressively attack eukaryotic mem-
branes (8, 9). To bind and insert into microbial membranes, un-
folded AMPs like themagainins are thought to interact mainly via
electrostatic and/or hydrophobic interactions with the lipid bi-
layer. Insertion of the nonpolar side chains into the hydrophobic
core of the membrane is accompanied by a structural conversion
to a helical conformation and depolarization of the membrane
FIG 6 Attenuation of AMP antibacterial activity by polysorbate 20. E. coli
bacteria were incubated with either LL37 (A) or magainin-2B amide (B) at a
concentration of 100 g ml1 for 10 min in L broth. Peptides (o) and vehicle
(1/10 dilution of PBS in H2O) controls () were adjusted to either 0.5%
polysorbate 20 or an equal amount of diluent (H2O) before the addition of
bacteria. After incubation with antimicrobial peptide for 10min at room tem-
perature, the samples were serially diluted in L broth and plated on L agar
plates, followed by incubation overnight at 37°C. After this, the colonies were
enumerated for 50% CFU using the Reed-Muench method. †, No colonies
were recovered (100% kill). The vehicle controls were PBS, added to a final
dilution of 1:10 (vol/vol). The results of one representative experiment of two
experiments are shown.
FIG 7 Enhancement of AMP virucidal activity by NaF. VACV preparations
were divided into equal aliquots and adjusted 0 or 100 g ml1 LL37 or
magainin-2B, and 0 mM/(), 250 mM (o), or 500 mM ( ) NaF, followed by
incubation at 37°C for 60 min. Vehicle controls were a 1/10 dilution of PBS in
H2O. Virus was quantitated by Reed-Muench limiting dilution. Data are pre-
sented as means and standard deviations of triplicate samples. The results of
one representative experiment of two experiments are shown.
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through the formation of pores (24, 25). In contrast to magainin-
2B, LL-37 has a significant degree of -helix in solutions that
mimic physiological salt conditions (23), probably due to the am-
phipathic character of residues 11 to 32. This region contains three
heptad repeats of the form (abcdefg)n with hydrophobic residues
occupying positions a and d; thus, this region could serve as an
assembly site for forming an -helical coiled coil (26). It is inter-
esting to speculate that the different degrees of -helix of LL-37
and magainin-2B in physiological buffers may be responsible for
the differential activity of the AMPs in physiological buffer in the
absence of polysorbate 20, whereby LL37 in physiological buffer
has greater activity against VACV than magainin-2B, whereas the
reverse is true for activity against E. coli and S. aureus.
Our results showing that polysorbate 20 modulates AMP ac-
tivity against bacteria and VACV in opposite directions are a
strong indication that AMPs act on the different targets by differ-
ent mechanisms. The correlation of the effects of polysorbate 20
and ionic strength on (i) AMP secondary structure, (ii) bacteri-
cidal activity, and (iii) virucidal activity suggest that the relation-
ship between secondary structure in aqueous solution andmicro-
bicidal activity is causal. The data further suggest that for optimal
bactericidal activity the AMP should adopt unstructured confor-
mationprior to interactionwith the targetmembrane, and that for
optimal virucidal activity it should adopt -helical conformation
prior to interaction with the target membrane (Fig. 8). Although
high -helical content is known to be an important feature of
bactericidal AMPs (8, 9, 27, 28), prefolding into an -helix in
solution may attenuate the ability to insert into both Gram-posi-
tive and Gram-negative bacterial membranes, but enhance the
ability to insert into some eukaryotic membranes. In essence, the
secondary structure of the AMP in solution can be seen as increas-
ing or decreasing the effective concentration of AMP for a given
target membrane without altering the absolute concentration in
the preparation. Previous work has shown that linear AMPs
degrade VACV membranes by a carpet-based mechanism (16),
whereas bactericidal activity is more commonly ascribed to pore
formation (24, 25). Our data indicate that a single peptidemay act
by more than one mode of membrane attack. It seems possible
that a carpet mechanism and pore formation are differentially
favored under conditions such as those we have used and, con-
ceivably, are differentially effective against the different types of
target membrane.
This study suggests that formulation as an aqueous solution
will present difficulties for the clinical development of AMPs for
FIG 8 Schematic representation of the influence of secondary structure of a linear AMP on bacterial and viral membrane interactions. (A) In a helix-promoting
formulation such as polysorbate 20 or elevated ionic strength, the AMP secondary structure is biased toward adopting an -helix. The helical AMP readily
associates with the virus membrane, causing it to fragment. The helical AMP does not readily interact with the bacterial membrane, leaving the bacterium still
viable. (B) In a helix-resisting formulation, such as low-ionic-strength buffer, the AMP secondary structure is biased toward unstructured conformation. The
unstructured AMP readily associates with the bacterial membrane, converting to a helical conformation in the membrane and forming depolarizing pores. The
unstructured AMP does not readily interact with the virus membrane leaving the virus still viable.
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treatment of systemic infections. However, we have described a
structural requirement for AMP activity prior to association with
a target membrane and how preformed secondary structure can
affect selectivity for target membranes. This will facilitate wider
efforts to develop complex formulations to maintain desirable
secondary structure after systemic administration.
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